Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration: 2-Year Results: Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group

OBJECTIVE: To describe effects of ranibizumab and bevacizumab when administered monthly or as needed for two years and to describe the impact of switching to as-needed treatment after a year of monthly treatment. DESIGN: Multicenter, randomized clinical trial. PARTICIPANTS: Patients (N=1107) who wer...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Martin, Daniel F., Maguire, Maureen G., Fine, Stuart L., Ying, Gui-shuang, Jaffe, Glenn J., Grunwald, Juan E., Toth, Cynthia, Redford, Maryann, Ferris, Frederick L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389193/
https://ncbi.nlm.nih.gov/pubmed/22555112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.03.053
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi